Symptom-centric view
Injection site rash
Substances reporting Injection site rash disproportionately — ranked by ROR.
showing 1 of 1
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tirzepatide Mounjaro · Zepbound | 8.0 [7.6–8.4] | 1,517 | glp-1 | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).